4.8 Article

Metformin for the treatment of the polycystic ovary syndrome

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 358, Issue 1, Pages 47-54

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMct0707092

Keywords

-

Funding

  1. FIC NIH HHS [D43TW007692] Funding Source: Medline
  2. NICHD NIH HHS [R01 HD035629, R01HD035629] Funding Source: Medline
  3. PHS HHS [K24D040237] Funding Source: Medline

Ask authors/readers for more resources

A 23- year- old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual periods per year and is not interested in becoming pregnant now, but she will be getting married in a year. She has heard that the polycystic ovary syndrome is associated with diabetes and is concerned because both her mother and father have type 2 diabetes. Her body-mass index ( the weight in kilograms divided by the square of the height in meters) is 32, her waist circumference is 38 in. ( 96.5 cm), her serum total testosterone level is elevated at 0.9 ng per milliliter ( 90 ng per deciliter, or 2.9 nmol per liter), her plasma high- density lipoprotein cholesterol level is 35 mg per deciliter ( 0.9 mmol per liter), and her triglyceride level is 190 mg per deciliter ( 2.1 mmol per liter). Her serum glucose level 2 hours after the ingestion of 75 g of dextrose is 138 mg per deciliter ( 7.7 mmol per liter). The physician wonders whether treatment with metformin would be beneficial and refers the patient to an endocrinologist.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available